<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03658200</url>
  </required_header>
  <id_info>
    <org_study_id>NL63106.068.17</org_study_id>
    <nct_id>NCT03658200</nct_id>
  </id_info>
  <brief_title>Fully Automated Scan Technique Optimisation of Scan Timing in Chest CT</brief_title>
  <acronym>[FAST-START]</acronym>
  <official_title>Fully Automated Scan Technique Optimisation of Scan Timing in Chest CT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Computed Tomography Angiography (CTA) is a non-invasive imaging tool widely used for various&#xD;
      indications. Contrast media (CM) is used to enhance the intravascular lumen and organ&#xD;
      parenchyma, depending on the indication. Recent technical advances in CT scan techniques&#xD;
      allow for a very fast scan acquisition with substantially increased image quality in terms of&#xD;
      temporal and spatial resolution. However, with faster scan acquisition, challenges arise with&#xD;
      regard to CM bolus timing. The risk of outrunning the CM bolus in these fast acquisitions is&#xD;
      higher, resulting in a decreased intravascular attenuation and subsequent hypothetical&#xD;
      increase in non-diagnostic image quality.&#xD;
&#xD;
      Previous studies have investigated the reduction of CM volume. When reducing the CM volume,&#xD;
      the total injection time decreases and the window of peak enhancement shortens and becomes&#xD;
      more narrow. The latter increases when injecting small CM volumes with higher flow rates.&#xD;
      Although the peak enhancement increases, the window of peak enhancement decreases more&#xD;
      rapidly. Thus, when administered with the same flow rate, the peak of the enhancement curve&#xD;
      will be lower, narrower and faster compared to larger CM volumes. This, in combination with&#xD;
      the faster scan acquisition makes the timing of the start of the scan highly important, since&#xD;
      scanning at the peak enhancement is necessary to achieve a diagnostic image quality.&#xD;
&#xD;
      New bolus tracking auto-delay software (Fully Automated Scan Technique, FAST, Siemens&#xD;
      Healthineers) automatically estimates the delay needed to scan at the peak of the enhancement&#xD;
      curve. With help of this software, the optimal individual scan delay and enhancement can be&#xD;
      achieved, and the risk of non-diagnostic scans should decrease. Therefore, this study aims to&#xD;
      evaluate the performance of the Bolus Tracking Auto-Delay (FAST) software in patients&#xD;
      receiving a standard chest CT with regard to the number of non-diagnostic scans (&lt; 300 HU)&#xD;
      and compare this with standard care (manual set pre-scan delay).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Computed Tomography Angiography (CTA) is a non-invasive imaging tool widely used for various&#xD;
      indications. Contrast media (CM) is used to enhance the intravascular lumen and organ&#xD;
      parenchyma, depending on the indication. Recent technical advances in CT scan techniques&#xD;
      allow for a very fast scan acquisition with substantially increased image quality in terms of&#xD;
      temporal and spatial resolution. These faster scan times account for a significant reduction&#xD;
      in radiation dose, which is desirable in light of the &quot;As Low As Reasonably Achievable&quot;&#xD;
      (ALARA) principle. Another advantage of the newer 'high-end' scanners is the use of lower&#xD;
      tube voltages and lower CM volumes, since many studies have shown that CM volumes can be&#xD;
      reduced with usage of lower tube voltages.&#xD;
&#xD;
      However, with faster scan acquisition, challenges arise with regard to CM bolus timing. The&#xD;
      risk of outrunning the CM bolus in these fast acquisitions is higher, subsequently leading to&#xD;
      a decreased or even non-diagnostic enhancement (in Hounsfield Units (HU)). In addition,&#xD;
      decreased CM volumes due to usage of lower tube voltages also add to the risk of outrunning&#xD;
      the bolus. When reducing the CM bolus, the injection time decreases and the window of peak&#xD;
      enhancement is shorter and more narrow. Also, when injecting these smaller CM volumes at&#xD;
      higher flow rates, although the peak enhancement is increased, the window of peak enhancement&#xD;
      decreases more rapidly. Thus, when administered with the same flow rate, the peak of the&#xD;
      enhancement curve will be lower, narrower and faster compared to larger CM volumes. This, in&#xD;
      combination with the faster scan acquisition makes the timing of the start of the scan (scan&#xD;
      start delay) highly important, since scanning at the peak enhancement is necessary to achieve&#xD;
      a diagnostic image quality.&#xD;
&#xD;
      To determine scan delay, two techniques frequently used in daily clinical routine are the&#xD;
      'test bolus' and 'bolus tracking' technique. With the first, a smaller CM bolus is&#xD;
      administered before the actual scan, and the time to peak of the intravascular enhancement is&#xD;
      determined with help of dedicated software (DynEva, Siemens Healthineers, Forchheim,&#xD;
      Germany). When using the 'bolus tracking' technique, no additional CM volume is administered.&#xD;
      A region of interest (ROI) is placed in a large artery of interest (e.g. ascending or&#xD;
      descending aorta), and a threshold enhancement is set prior to the scan (e.g. 100 HU).&#xD;
      Repetitive low dose scans are acquired at the same level and the arrival of the CM bolus is&#xD;
      followed. Once the threshold is reached, the scanner automatically starts the scan. Between&#xD;
      reaching the threshold and the actual start of the scan, a manual post-tracking delay is set&#xD;
      prior to scanning. This delay is necessary for both the table movement of the scanner to the&#xD;
      start of the scan and the breath hold command. The problem is that this manual post-tracking&#xD;
      delay is set prior to the scan, without information of the patient's cardiovascular dynamics&#xD;
      (e.g. cardiac output). Since cardiac output can vary greatly inter- and intra-patient, this&#xD;
      fixed post-tracking delay may not be appropriate for all patients. Scanning with a&#xD;
      sub-optimal post tracking delay could potentially result in suboptimal arterial enhancement&#xD;
      and insufficient diagnostic quality.&#xD;
&#xD;
      With new bolus tracking auto-delay software (Fully Automated Scan Technique, FAST, Siemens&#xD;
      Healthineers) the incidence of scans made at a suboptimal attenuation could be reduced. This&#xD;
      software is similar to the 'bolus tracking' technique, the difference is that the manual&#xD;
      post-tracking delay is calculated automatically by the software. During the low-dose&#xD;
      repetitive scans at the level of the ROI, the attenuation in the ROI is used to predict the&#xD;
      optimal enhancement curve. The software takes the injection protocol, tube voltage and&#xD;
      patient parameters into account. A previously acquired database of numerous enhancement&#xD;
      curves is consulted to predict a best fitted enhancement curve of the individual patient. The&#xD;
      software then calculates the optimal post-tracking scan delay to scan at the peak&#xD;
      enhancement. Thus, the optimal individual scan delay and enhancement based on the patients&#xD;
      physiology can be achieved, and the risk of non-diagnostic scans should decrease. Therefore,&#xD;
      this study aims to evaluate the performance of the FAST software in patients receiving&#xD;
      standard chest CT with regard to the number of non-diagnostic scans (&lt; 300 HU) and compare&#xD;
      this with standard care (manual set pre-scan delay).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Interim analysis showed primary outcome was not going to be achieved.&#xD;
  </why_stopped>
  <start_date type="Actual">April 5, 2018</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intravascular enhancement</measure>
    <time_frame>2 years</time_frame>
    <description>To evaluate the performance of the FAST software in patients receiving a thoracic CTA with regard to the number of non-diagnostic scans (&lt; 300 HU) in comparison with standard care (manual scan delay).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Enhancement curves</measure>
    <time_frame>2 years</time_frame>
    <description>To assess the enhancement curves calculated by the FAST software with regards to scan timing and delay and compare it with the scan timing and delay of the control group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intravascular attenuation</measure>
    <time_frame>2 years</time_frame>
    <description>To assess the objective image quality with regard to intravascular attenuation in patients receiving standard CTA of the thorax with the FAST software.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Image noise</measure>
    <time_frame>2 years</time_frame>
    <description>To assess the objective image quality with regard to image noise in patients receiving standard CTA of the thorax with the FAST software.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Signal-to-noise</measure>
    <time_frame>2 years</time_frame>
    <description>To assess the objective image quality with regard to signal-to-noise in patients receiving standard CTA of the thorax with the FAST software.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast-to-noise</measure>
    <time_frame>2 years</time_frame>
    <description>To assess the objective image quality with regard to contrast-to-noise in patients receiving standard CTA of the thorax with the FAST software.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective image quality</measure>
    <time_frame>2 years</time_frame>
    <description>To assess the subjective (Likert scale) image quality parameters in patients receiving standard CTA of the thorax with the FAST software. a 4-point Likert scale will be used:&#xD;
4: Excellent, absence of any image-degrading artefacts related to breathing or noise;&#xD;
3: Good, presence of few minor image-degrading artefacts related to breathing or noise;&#xD;
2: Moderate, presence of some image-degrading artefacts related to breathing or noise, with influence on image and diagnostic quality;&#xD;
1: Poor, presence of image-degrading artefacts related to breathing or noise with severe influence on image and diagnostic quality.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">223</enrollment>
  <condition>Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>FAST software</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient referred for chest CT and scanned with delay based on bolus tracking with FAST software. intervention: FAST START Software delay</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient referred for chest CT and scanned with delay based on bolus tracking without FAST software. Intervention: Manual bolus tracking delay</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>FAST start software delay</intervention_name>
    <description>Scan delay will be determined by the FAST software bolus tracking technique. Before the start of bolus tracking (the time between start injection and start bolus tracking), a delay of 8 s is chosen. Bolus tracking threshold is set at 100 HU with a cycle time of 1.13 s and scan time of 0.25 s. After reaching the 100 HU threshold the FAST START software calculates the delay.</description>
    <arm_group_label>FAST software</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Manual bolus tracking delay</intervention_name>
    <description>Scan delay will be determined by the standard bolus tracking technique. Before the start of bolus tracking (the time between start injection and start bolus tracking), a delay of 8 s is chosen. Bolus tracking threshold is set at 100 HU with a cycle time of 1.13 s and scan time of 0.25 s. After reaching the 100 HU threshold a delay of 6 s is chosen (table movement and breath hold command) and the scan starts.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients referred for standard chest CT&#xD;
&#xD;
          -  Patients older than 18 years and competent to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hemodynamic instability;&#xD;
&#xD;
          -  Pregnancy;&#xD;
&#xD;
          -  Renal insufficiency (defined as Glomerular Filtration Rate (GFR) &lt; 30 mL/min (Odin&#xD;
             protocol 004720));&#xD;
&#xD;
          -  Iodine allergy;&#xD;
&#xD;
          -  Age &lt;18 years;&#xD;
&#xD;
          -  Absence of informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joachim E Wildberger, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6202 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Bae KT. Intravenous contrast medium administration and scan timing at CT: considerations and approaches. Radiology. 2010 Jul;256(1):32-61. doi: 10.1148/radiol.10090908. Review.</citation>
    <PMID>20574084</PMID>
  </reference>
  <reference>
    <citation>Funama Y, Awai K, Nakayama Y, Kakei K, Nagasue N, Shimamura M, Sato N, Sultana S, Morishita S, Yamashita Y. Radiation dose reduction without degradation of low-contrast detectability at abdominal multisection CT with a low-tube voltage technique: phantom study. Radiology. 2005 Dec;237(3):905-10. Epub 2005 Oct 19.</citation>
    <PMID>16237139</PMID>
  </reference>
  <reference>
    <citation>Huda W, Scalzetti EM, Levin G. Technique factors and image quality as functions of patient weight at abdominal CT. Radiology. 2000 Nov;217(2):430-5.</citation>
    <PMID>11058640</PMID>
  </reference>
  <reference>
    <citation>Nakayama Y, Awai K, Funama Y, Hatemura M, Imuta M, Nakaura T, Ryu D, Morishita S, Sultana S, Sato N, Yamashita Y. Abdominal CT with low tube voltage: preliminary observations about radiation dose, contrast enhancement, image quality, and noise. Radiology. 2005 Dec;237(3):945-51. Epub 2005 Oct 19.</citation>
    <PMID>16237140</PMID>
  </reference>
  <reference>
    <citation>Kok M, Mihl C, Hendriks BM, Altintas S, Kietselaer BL, Wildberger JE, Das M. Optimizing contrast media application in coronary CT angiography at lower tube voltage: Evaluation in a circulation phantom and sixty patients. Eur J Radiol. 2016 Jun;85(6):1068-74. doi: 10.1016/j.ejrad.2016.03.022. Epub 2016 Mar 22.</citation>
    <PMID>27161054</PMID>
  </reference>
  <reference>
    <citation>Kok M, Mihl C, Seehofnerov√° A, Turek J, Jost G, Pietsch H, Haberland U, Wildberger JE, Das M. Automated Tube Voltage Selection for Radiation Dose Reduction in CT Angiography Using Different Contrast Media Concentrations and a Constant Iodine Delivery Rate. AJR Am J Roentgenol. 2015 Dec;205(6):1332-8. doi: 10.2214/AJR.14.13957.</citation>
    <PMID>26587942</PMID>
  </reference>
  <reference>
    <citation>Korporaal JG, Bischoff B, Arnoldi E, Sommer WH, Flohr TG, Schmidt B. Evaluation of A New Bolus Tracking-Based Algorithm for Predicting A Patient-Specific Time of Arterial Peak Enhancement in Computed Tomography Angiography. Invest Radiol. 2015 Aug;50(8):531-8. doi: 10.1097/RLI.0000000000000160.</citation>
    <PMID>25900084</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>April 25, 2018</study_first_submitted>
  <study_first_submitted_qc>September 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2018</study_first_posted>
  <last_update_submitted>March 19, 2019</last_update_submitted>
  <last_update_submitted_qc>March 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maastricht University Medical Center</investigator_affiliation>
    <investigator_full_name>Joachim Wildberger</investigator_full_name>
    <investigator_title>Prof. Dr. J.E. Wildberger</investigator_title>
  </responsible_party>
  <keyword>Chest CT</keyword>
  <keyword>Bolus tracking</keyword>
  <keyword>Image quality</keyword>
  <keyword>Contrast media</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

